Fungemia with Co-isolation of Candida parapsilosis and Trichosporon asahii Confirmed by MALDI-TOF MS and D 2 rRNA Sequencing
暂无分享,去创建一个
Jong Do Seo | M. Seong | S. Park | N. Kim | T. Kim | E. Kim | K. Park | Junghan Song | S. M. Hwang | J. Park | Y. J. Hong | Yun Ji Hong
[1] Won-Kil Lee,et al. A Case of Trichosporon asahii Fungemia with Urinary Tract Infection as a Primary Focus , 2015 .
[2] Mina Kim,et al. Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea. , 2010, Medical mycology.
[3] A. Colombo,et al. Bloodstream Infections Due to Trichosporon spp.: Species Distribution, Trichosporon asahii Genotypes Determined on the Basis of Ribosomal DNA Intergenic Spacer 1 Sequencing, and Antifungal Susceptibility Testing , 2009, Journal of Clinical Microbiology.
[4] S. Suh,et al. Species Distribution and Susceptibility to Azole Antifungals of Candida Bloodstream Isolates from Eight University Hospitals in Korea , 2007, Yonsei medical journal.
[5] M. Pfaller,et al. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.
[6] Ronald N. Jones,et al. International Surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003) , 2006, Journal of Clinical Microbiology.
[7] M. Cuenca‐Estrella,et al. Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003 , 2006, Journal of Clinical Microbiology.
[8] M. Bassetti,et al. Epidemiological trends in nosocomial candidemia in intensive care , 2006, BMC infectious diseases.
[9] L. Pagano,et al. Design and Methods , 2022 .
[10] S. Fridkin,et al. Epidemiologic and Molecular Characterization of an Outbreak of Candida parapsilosis Bloodstream Infections in a Community Hospital , 2004, Journal of Clinical Microbiology.
[11] R. Wenzel,et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] D. Kontoyiannis,et al. Trichosporonosis in a tertiary care cancer center: Risk factors, changing spectrum and determinants of outcome , 2004, Scandinavian journal of infectious diseases.
[13] T. Boekhout,et al. Co-isolation of Trichosporon inkin and Candida parapsilosis from a scalp white piedra case. , 2004, Medical mycology.
[14] T J Walsh,et al. Infections due to emerging and uncommon medically important fungal pathogens. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] D. Wolf,et al. Multidrug-Resistant Trichosporon asahii Infection of Nongranulocytopenic Patients in Three Intensive Care Units , 2001, Journal of Clinical Microbiology.
[16] M. Pfaller,et al. International Surveillance of Bloodstream Infections Due toCandida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program , 2001, Journal of Clinical Microbiology.
[17] Peggo K. W. Lam,et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] J. Weems. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] S. Lipton,et al. Candidal infection in the central nervous system. , 1984, American Journal of Medicine.